Kings College Hospital - Exemplar Centre - News and Events
 
News and Events


VTE prevention toolkit launched

A new toolkit entitled ‘Preventing Venous Thromboembolism in Hospital - A Toolkit for Assessing and Improving Clinical Practice in Trusts’ has been created and launched by Bayer Schering Pharma in partnership with Anticoagulation Europe, as a guide in assessing and improving clinical practice in the prevention of venous thromboembolism (VTE) in hospital.

For further information or to request this Toolkit, please provide your details to Bayer Schering Pharma through the Thrombosis Adviser website. 

 

 

Why a Thromboprophylaxis Service Assessment Toolkit?

 

This toolkit has been developed in collaboration with a multidisciplinary team of NHS healthcare professionals and Trust managers to make life easier for anyone involved in providing, managing or commissioning VTE thromboprophylaxis. Whatever your role in the implementation or management of local VTE thromboprophylaxis, you should find a number of useful resources in this toolkit.

Depending on your local needs, the toolkit should help you to:


  • Assess your current VTE thromboprophylaxis service
  •  
  • Design appropriate objectives at every level to achieve full implementation of thromboprophylaxis
  •  
  • Support local action in meeting these objectives by providing you with a range of resources.
 

This process of improving local thromboprophylaxis is in line with the latest NHS Confederation briefing on reducing deaths from blood clots in hospitals1.

The toolkit offers practical solutions to the wide-ranging challenges associated with the effective local implementation and management of VTE thromboprophylaxis, by:


  • Helping healthcare professionals to gain a better understanding of the burden of VTE in general, the need for action, and the range of currently available guidelines on VTE thromboprophylaxis
  •  
  • Providing a practical guide and framework to facilitate the overall assessment of local VTE thromboprophylaxis services (including local VTE risk assessment methods), identify any gaps, and determine whether specific action is needed
  •  
  • Offering a range of resources that may be used to support local action in addressing any gaps identified, backed up by examples of how other organisations have tackled the problem in their own locality
 

The resources in this toolkit should therefore help Trusts to achieve - and demonstrate -
compliance with best practice in VTE prevention ahead of any future CQC assessment.

 

Toolkit Audience

 

This toolkit is suitable for use by anyone who is involved in the provision, management and
commissioning of VTE thromboprophylaxis services.

 
  • Providers of VTE thromboprophylaxis (e.g. consultants, nurses, pharmacists, primary care clinicians) and Trust managers can use this toolkit to assess their own compliance with the latest national guidance in a realistic manner, to set objectives for improvement - and potentially, to reduce clinical, operational and financial risk in practice
  •  
  • Commissioners of healthcare can use this toolkit to assess the problem of VTE across their healthcare community, to prioritise investment - and to support contracting and performance monitoring processes
 

SECTION 1

 

Introduction and Background

 

Objective: An overview of VTE prevention, and advice on how to use the toolkit to enhance clinical practice in your Trust

 

SECTION 2

 

Overview of Organisational Thromboprophylaxis Baseline Assessment

 

Objective: Step-by-step guidance on how to assess your Trust's performance in terms of VTE risk assessment and thromboprophylaxis

 

SECTION 3

 

The Organisational Thromboprophylaxis Assessment and Implementation Tool

 

Objective: Practical advice and support on how to establish effective measures to prevent VTE in your Trust

 

 

 

Reference:

1 - NHS Confederation briefing: Reducing deaths from blood clots in hospitals. May 2009.

 

                                                                                                                                                                                                                                                                              





Friday, March 5, 2010